Flector and Nosebleed - a phase IV clinical study of FDA data

Summary:

Nosebleed is reported as a side effect among people who take Flector (diclofenac epolamine), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Nexium, and have Blood pressure abnormal.

The phase IV clinical study analyzes which people have Nosebleed when taking Flector. It is created by eHealthMe based on reports of 5,075 people who have side effects when taking Flector from the FDA, and is updated regularly.

What is Flector?

Flector has active ingredients of diclofenac epolamine. It is often used in pain. eHealthMe is studying from 5,112 Flector users. Check the latest studies of Flector.

What is Nosebleed?

Nosebleed (bleeding from nose) is found to be associated with 2,074 drugs and 3,093 conditions by eHealthMe. Check the latest studies of Nosebleed.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 10, 2026

5,075 people reported to have side effects when taking Flector.
Among them, 17 people (0.33%) have Nosebleed.

Among these 17 people:

How long have people been on Flector when they have Nosebleed? *

What is the gender of people who have Nosebleed when taking Flector? *

female: 82.35 %
male: 17.65 %

What is the age of people who have Nosebleed when taking Flector? *

What are other drugs people take besides Flector? *

What are other side effects people have besides Nosebleed? *

Heart Palpitations (feelings or sensations that your heart is pounding or racing): 9 people, 52.94%
Dyspnea (difficult or laboured breathing): 8 people, 47.06%
Weight Increased: 7 people, 41.18%
Hypoaesthesia (reduced sense of touch or sensation): 7 people, 41.18%
Stress And Anxiety: 7 people, 41.18%
Fatigue (feeling of tiredness): 7 people, 41.18%
Malaise (a feeling of general discomfort or uneasiness): 7 people, 41.18%
Gait Disturbance: 7 people, 41.18%
Tooth Fracture: 6 people, 35.29%
Weight Decreased: 6 people, 35.29%

What are the existing conditions these people have? *

Abdominal Discomfort: 5 people, 29.41%
High Blood Cholesterol: 5 people, 29.41%
Glaucoma (increased fluid pressure in the eye with vision loss): 5 people, 29.41%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 5 people, 29.41%
Infection: 5 people, 29.41%
Intraocular Pressure Increased: 5 people, 29.41%
Laryngeal Disorder (disease of larynx related to voice): 5 people, 29.41%
Cataract (clouding of the lens inside the eye): 5 people, 29.41%
Cardiac Disorder: 5 people, 29.41%
Blood Pressure Abnormal: 5 people, 29.41%

* Approximation only. Some reports may have incomplete information.

Do you take Flector and have Nosebleed?

- Check whether Nosebleed is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Flector:

Flector (5,112 reports)

Nosebleed treatments and more:

Nosebleed (92,075 reports)

Browse all side effects of Flector:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nosebleed:

Nosebleed (2,074 drugs)

Browse all the conditions that are associated with Nosebleed:

Nosebleed (3,093 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on diclofenac epolamine (the active ingredients of Flector) and Flector (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.